Speakers: Natalie Jackson, RN, MSN, CRNP and Suzanne McGettigan, MSN, CRNP, AOCN
Checkpoint inhibitors are being used for a growing number of oncologic indications. As we learn more about these agents, we learn more about their associated adverse events. Endocrine and rheumatologic adverse events are well documented, and clinicians need to be well-versed in their assessment, diagnosis, and management. This webinar provides an overview of endocrine and rheumatologic immune-related adverse events, their assessment and grading, as well as management and practice pearls.
CNE is temporarily unavailable while ONS upgrades its platform, but check back on December 17 to earn free CNE for this recorded webinar. This activity is worth .5 contact hours of CNE.